Skip to content
Trial Eligibility
Menu

Dietary Intervention for Migraine Relief

NCT07360405

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to evaluate whether a low-glutamate diet can improve migraine symptoms in adults with migraine and to explore possible biological changes associated with dietary improvement. The study focuses on whether reducing dietary glutamate intake may influence processes involved in migraine, such as brain excitation, inflammation, and oxidative stress. The main questions this study aims to answer are: Does following a low-glutamate diet reduce the number of migraine days and the severity and duration of migraine attacks, and improve quality of life?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Migraine

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 75 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
American University
Last updated on ClinicalTrials.gov
October 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

District of Columbia · 1

  • American University · Washington D.C., DC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.